Literature DB >> 8522717

Natural history of severe atheromatous disease of the thoracic aorta: a transesophageal echocardiographic study.

D H Montgomery1, J J Ververis, G McGorisk, S Frohwein, R P Martin, W R Taylor.   

Abstract

OBJECTIVES: This study sought to prospectively observe the morphologic and clinical natural history of severe atherosclerotic disease of the thoracic aorta as defined by transesophageal echocardiography.
BACKGROUND: Atherosclerosis of the thoracic aorta has been shown to be highly associated with risk for embolic events in transesophageal studies, but the natural history of the disease under clinical conditions has not been reported.
METHODS: During a 20-month period, 191 of 264 patients undergoing transesophageal echocardiography had adequate visualization of the aorta to allow atherosclerotic severity to be graded as follows: grade I = normal (44 patients); grade II = intimal thickening (52 patients); grade III = atheroma < 5 mm (62 patients); grade IV = atheroma > or = 5 mm (19 patients); grade V = mobile lesion (14 patients). All available patients with grades IV (8 patients) and V (10 patients) disease as well as a subgroup of 12 patients with grade III disease had follow-up transesophageal echocardiographic studies (mean [+/- SD] 11.7 +/- 0.9 months, range 6 to 22).
RESULTS: Of 30 patients undergoing follow-up transesophageal echocardiographic studies, 20 (66%) had no change in atherosclerotic severity grade. Of the remaining 10 patients, atherosclerotic severity progressed one grade in 7 and decreased in 3 with resolved mobile lesions. Of 18 patients with grade IV or V disease of the aorta who underwent a follow-up study, 11 (61%) demonstrated formation of new mobile lesions. Of 10 patients with grade V disease on initial study who underwent follow-up study, 7 (70%) demonstrated resolution of a specific previously documented mobile lesion. However, seven patients (70%) with grade V disease also demonstrated development of a new mobile lesion. Of 33 patients with grade IV or V disease, 8 (24%) died during the study period, and 1 (3%) had a clinical embolic event.
CONCLUSIONS: The presence of severe atherosclerotic disease of the thoracic aorta as defined by transesophageal echocardiography is associated with a high mortality rate. Although the morphologic natural history of the disease process itself is marked by stability over a 1-year period, individual lesion morphology is dynamic, with formation and resolution of mobile components occurring frequently over the same period. The dynamic nature of individual lesion morphology potentially enhances the possibility of developing a successful therapeutic strategy.

Entities:  

Mesh:

Year:  1996        PMID: 8522717     DOI: 10.1016/0735-1097(95)00431-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

1.  Epicardial adipose tissue thickness predicts descending thoracic aorta atherosclerosis shown by multidetector computed tomography.

Authors:  Hikmet Yorgun; Uğur Canpolat; Tuncay Hazırolan; Hamza Sunman; Ahmet Hakan Ateş; Kadri Murat Gürses; Ozgür Ertuğrul; Ergün Barış Kaya; Kudret Aytemir; Lale Tokgözoğlu; Giray Kabakçı; Ali Oto
Journal:  Int J Cardiovasc Imaging       Date:  2011-06-03       Impact factor: 2.357

2.  Detection of inflammation in aortic aneurysms with indium 111-oxine--labeled leukocyte imaging.

Authors:  K Takahashi; M Ohyanagi; K Ikeoka; M Masai; H Naruse; T Iwasaki; M Fukuchi; T Miyamoto
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

3.  Occlusive ascending aorta and arch atheroma treated with deep hypothermic circulatory arrest and thromboendarterectomy.

Authors:  Katie E O' Sullivan; Sarah A Early; Leo Lawler; John Hurley
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-08-15

4.  Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia.

Authors:  S P Glasser; W Frishman; W B White; P Stone; M F Johnson
Journal:  Clin Cardiol       Date:  2000-07       Impact factor: 2.882

5.  Relation of transesophageal echocardiographic findings to subtypes of cerebral infarction in patients with atrial fibrillation.

Authors:  N Shinokawa; T Hirai; S Takashima; T Kameyama; Y Obata; K Nakagawa; H Asanoi; H Inoue
Journal:  Clin Cardiol       Date:  2000-07       Impact factor: 2.882

6.  Incidence and severity of atherosclerotic cardiovascular artery disease in patients undergoing TAVI.

Authors:  Laura Fusini; Oana Mirea; Gloria Tamborini; Manuela Muratori; Paola Gripari; Claudia Cefalù; Sarah Ghulam Ali; Francesco Maffessanti; Daniele Andreini; Gianluca Pontone; Antonio L Bartorelli; Francesco Alamanni; Marco Agrifoglio; Mauro Pepi
Journal:  Int J Cardiovasc Imaging       Date:  2015-03-25       Impact factor: 2.357

7.  Complex atheromatosis of the aortic arch in cerebral infarction.

Authors:  Ramón Pujadas Capmany; Montserrat Oliveras Ibañez; Xavier Jané Pesquer
Journal:  Curr Cardiol Rev       Date:  2010-08

8.  Aortic Source of Brain Embolism.

Authors:  Geoffrey A. Donnan; Stephen M. Davis; Elizabeth F. Jones; Pierre Amarenco
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-07

Review 9.  Aortic arch plaque in stroke.

Authors:  Souvik Sen
Journal:  Curr Cardiol Rep       Date:  2009-01       Impact factor: 2.931

10.  Association of Dietary Factors with Progression of AA in Stroke/TIA Patients.

Authors:  Nishanth Kodumuri; Lauren Giamberardino; Alan Hinderliter; Souvik Sen
Journal:  J Neurol Disord       Date:  2016-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.